Study #2019-0455
A Phase I Study of DFP-14927 in Patients with Advanced Solid Tumors(D18-11161)
MD Anderson Study Status
Enrolling
Treatment Agent
DFP-14927
Description
This is a Phase I, open-label, single-arm, dose escalation study of DFP-14927 intravenous infusion administered to patients with refractory or relapsed solid tumors.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Solid Tumor, Cancer
Study phase:
Phase I
Physician name:
Jaffer Ajani
Department:
Gastrointestinal Medical Oncology
For general questions about clinical trials:
1-844-335-7393
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.